Citation: Sr. Majumdar et al., Undertreatment of hyperlipidemia in the secondary prevention of coronary artery disease, J GEN INT M, 14(12), 1999, pp. 711-717
Authors:
Rochon, PA
Anderson, GM
Tu, JV
Clark, JP
Gurwitz, JH
Szalai, JP
Lau, P
Citation: Pa. Rochon et al., Use of beta-blocker therapy in older patients after acute myocardial infarction in Ontario, CAN MED A J, 161(11), 1999, pp. 1403-1408
Citation: Se. Andrade et al., The effect of an Rx-to-OTC switch on medication prescribing patterns and utilization of physician services - The case of H-2-receptor antagonists, MED CARE, 37(4), 1999, pp. 424-430
Authors:
McCormick, D
Gurwitz, JH
Lessard, D
Yarzebski, J
Gore, JM
Goldberg, RJ
Citation: D. Mccormick et al., Use of aspirin, beta-blockers, and lipid-lowering medications before recurrent acute myocardial infarction - Missed opportunities for prevention?, ARCH IN MED, 159(6), 1999, pp. 561-567
Citation: Rj. Goldberg et al., Duration of, and temporal trends (1994-1997) in, prehospital delay in patients with acute myocardial infarction - The Second National Registry of Myocardial Infarction, ARCH IN MED, 159(18), 1999, pp. 2141-2147
Authors:
Soumerai, SB
McLaughlin, TJ
Gurwitz, JH
Pearson, S
Christiansen, CL
Borbas, C
Morris, N
McLaughlin, B
Gao, XM
Ross-Degnan, D
Citation: Sb. Soumerai et al., Timeliness and quality of care for elderly patients with acute myocardial infarction under health maintenance organization vs fee-for-service insurance, ARCH IN MED, 159(17), 1999, pp. 2013-2020
Authors:
Glynn, RJ
Monane, M
Gurwitz, JH
Choodnovskly, I
Avorn, J
Citation: Rj. Glynn et al., Agreement between drug treatment data and a discharge diagnosis of diabetes mellitus in the elderly, AM J EPIDEM, 149(6), 1999, pp. 541-549
Citation: Rj. Goldberg et Jh. Gurwitz, Disseminating the results of clinical trials to community-based practitioners: Is anyone listening?, AM HEART J, 137(1), 1999, pp. 4-7
Authors:
Rochon, PA
Anderson, GM
Tu, JV
Gurwitz, JH
Clark, JP
Shear, NH
Lau, P
Citation: Pa. Rochon et al., Age- and gender-related use of low-dose drug therapy: The need to manufacture low-dose therapy and evaluate the minimum effective dose, J AM GER SO, 47(8), 1999, pp. 954-959
Authors:
Field, TS
Gurwitz, JH
Glynn, RJ
Salive, ME
Gaziano, JM
Taylor, JO
Hennekens, CH
Citation: Ts. Field et al., The renal effects of nonsteroidal anti-inflammatory drugs in older people:Findings from the established populations for epidemiologic studies of theelderly, J AM GER SO, 47(5), 1999, pp. 507-511
Citation: Tj. Mclaughlin et al., Delayed thrombolytic treatment of older patients with acute myocardial infarction, J AM GER SO, 47(10), 1999, pp. 1222-1228
Authors:
Goldberg, RJ
McCormick, D
Gurwitz, JH
Yarzebski, J
Lessard, D
Gore, JM
Citation: Rj. Goldberg et al., Age-related trends in short- and long-term survival after acute myocardialinfarction: A 20-year population-based perspective (1975-1995), AM J CARD, 82(11), 1998, pp. 1311-1317